1. Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital
- Author
-
Patrick Henri, Isabelle Goyer, Jean-Jacques Parienti, Cécile Breuil, Alexandra Muzard, Youssef Oulkhouir, Yann Ollivier, Jean-Pierre Jourdan, Centre d'Etudes et de Recherche sur le Médicament de Normandie (CERMN), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU), Service de Pharmacie [CHU Caen], CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Laboratoire de Recherche en Informatique (LRI), Université Paris-Sud - Paris 11 (UP11)-CentraleSupélec-Centre National de la Recherche Scientifique (CNRS), UNIROUEN - UFR Santé (UNIROUEN UFR Santé), Université de Rouen Normandie (UNIROUEN), Centre Universitaire des Maladies Rénales [CHU Caen] (CUMR Caen), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), and Cellule Promotion de la Recherche Clinique [CHU Caen] (CPRC)
- Subjects
Male ,Psychological intervention ,Pharmaceutical Science ,Pharmacy ,Toxicology ,Pharmacists ,030226 pharmacology & pharmacy ,law.invention ,Hospitals, University ,0302 clinical medicine ,law ,Multidisciplinary approach ,Medicine ,Pharmacology (medical) ,030212 general & internal medicine ,Prospective Studies ,Child ,health care economics and organizations ,Aged, 80 and over ,Clinical pharmacy services ,[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences ,Middle Aged ,Intensive care unit ,3. Good health ,Hospitalization ,Intensive Care Units ,Treatment Outcome ,Child, Preschool ,Female ,Medical emergency ,France ,Public Health ,Health care costs ,Switzerland ,Adult ,medicine.medical_specialty ,Adolescent ,Cost Control ,Context (language use) ,Drug Prescriptions ,03 medical and health sciences ,Young Adult ,Cost Savings ,Humans ,Medical prescription ,Hospitals, Teaching ,Aged ,Pharmacology ,Presciption review ,business.industry ,Public health ,Infant ,medicine.disease ,Clinical pharmacy ,Pharmacist Interventions ,business - Abstract
International audience; Background A significant number of clinical pharmacy services have shown to improve in-hospital medication safety and patient outcome. Prescription review and pharmacist interventions are a fundamental part of hospital clinical pharmacy activities. In a context of restricted financial resources, proving the economic and clinical impact of this activity seems necessary. Objective The aim of this study was to assess the clinical impact on patient outcomes and economic benefit of prescription review by pharmacists. Setting 1624-bed tertiary French university teaching hospital. Method Prospective single center study evaluating prescriptions for which a pharmacist intervention was issued over a 6-month period. The clinical impact of every pharmacist intervention was evaluated by a multidisciplinary experts committee. Economic benefit was evaluated from the public health care system spending standpoint. Main outcome measures Number of avoided hospitalization days and associated public health care system cost-avoidance. Results Prescription review and interventions by pharmacists prevented 73 intensive care unit hospitalization days, 74 continuous monitoring unit hospitalization days and 66 days of conventional hospitalization. €252,294.00 in public health expenditure were thus prevented. For every Euro invested in the prescription review activity, €5.09 of public health spending were potentially saved. Conclusion Our study shows that prescription review and clinical pharmacists' interventions had an impact on clinical outcomes which translated into prevented hospitalization days. Prescription optimization through pharmacist interventions allows significant health care cost savings which makes this service highly efficient
- Published
- 2018